Gamma Investing LLC Axsome Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 64 shares of AXSM stock, worth $6,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64
Previous 189
66.14%
Holding current value
$6,563
Previous $22 Million
69.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
406Shares Held
36.1MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$338 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$300 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$173 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$100 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.4B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...